severe acute respiratory syndrome coronavirus 2
Showing 1 - 25 of 34
COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)
Not yet recruiting
- COVID 19 Disease
- +4 more
- Tafenoquine Oral Tablet
- Placebo
- (no location specified)
Jul 13, 2023
Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Bobo-Dioulasso, Conakry (Nitazoxanide
Recruiting
- Covid19
- +3 more
- Nitazoxanide and Ciclésonide
- +3 more
-
Bobo-Dioulasso, Burkina Faso
- +1 more
Jan 30, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-Cov-2 infection
-
Ferrara, ItalyAzienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022
SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron
Not yet recruiting
- SARS-CoV-2 Virus
- +2 more
- Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
- +4 more
- (no location specified)
Sep 14, 2022
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- +2 more
- Aminoterminal type III peptide of procollagen
- Lung computed tomography
-
Marseille, FranceHopital Europeen Marseille
Aug 7, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial (COVAC-2, Saline Placebo)
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVAC-2
- Saline Placebo
- (no location specified)
Aug 5, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Halifax, Saskatoon (COVAC-2, Saline Placebo)
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVAC-2
- Saline Placebo
-
Halifax, Nova Scotia, Canada
- +1 more
Aug 5, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive Trial in Orange, Sacramento, San Diego (Isavuconazonium
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- Aspergillosis Invasive
- Isavuconazonium Injection [Cresemba]
- Placebo
-
Orange, California
- +2 more
Jul 26, 2022
COVID-19, SARS-CoV 2, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in San Francisco (Oral-B Mouth Sore mouthwash, Crest
Recruiting
- COVID-19
- +5 more
- Oral-B Mouth Sore mouthwash
- +4 more
-
San Francisco, CaliforniaUniversity Of California, San Francisco
May 17, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial in Worldwide (SNG001, Placebo)
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVID-19
- SNG001
- Placebo
-
Tucson, Arizona
- +111 more
Mar 2, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Worldwide (Anti-Sars-CoV-2 Convalescent Plasma)
No longer available
- Severe Acute Respiratory Syndrome Coronavirus 2
- Anti-Sars-CoV-2 Convalescent Plasma
-
Oceanside, California
- +37 more
Feb 16, 2022
Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Distress Syndrome Trial in Paris (Umbilical cord
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- Severe Acute Respiratory Distress Syndrome
- Umbilical cord Wharton's jelly-derived human
- NaCl 0.9%
-
Paris, France
- +1 more
Feb 17, 2022
Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in United
Recruiting
- Coronavirus Infection
- +2 more
- Drug: NA-831
- +3 more
-
Los Angeles, California
- +30 more
Jan 31, 2022
Stratification With Chest CT to Rule-out Suspected SARS-CoV-2
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- CT-imaging
-
Jena, Thuringia, GermanyJena University Hospital
Sep 17, 2021
Beaumont Health Large-scale Automated Serologic Testing for
Completed
- COVID-19
- +2 more
- EUROIMMUN assay
-
Royal Oak, Michigan
- +1 more
Sep 2, 2021
Health and Infection Control Practices Among Dentists
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- No intervention
-
Chicago, IllinoisAmerican Dental Association
Jul 20, 2021
Prone Positioning and Regional Ventilation in Mechanically
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- +2 more
- Prone positioning
-
Geneva, SwitzerlandUniversity Hospitals of Geneva
Jul 20, 2021
COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Huixquilucan (Ruxolitinib Oral Tablet)
Completed
- COVID-19
- Severe Acute Respiratory Syndrome Coronavirus 2
- Ruxolitinib Oral Tablet
-
Huixquilucan, Estado De México, MexicoGrupo Cooperativo de Hemopatías Malignas
Jul 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Zárate (Transcutaneous Auricular Vagus Nerve Stimulation)
Completed
- Severe Acute Respiratory Syndrome Coronavirus 2
- Transcutaneous Auricular Vagus Nerve Stimulation
-
Zárate, Buenos Aires, ArgentinaHospital Zonal Virgen del Carmen de Zárate
Jun 1, 2021
COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)
Terminated
- COVID 19
- +14 more
- Linagliptin 5 MG
-
Be'er Ya'aqov, Israel
- +2 more
May 28, 2021
Communication in ICU During COVID-19
Completed
- COVID-19
- +2 more
- Communication
-
Dubai, United Arab EmiratesNMC Specialty Hospital
May 9, 2021
Severe Acute Respiratory Syndrome Coronavirus 2, Coronavirus Infection, Mild to Moderate COVID-19 Trial in Seoul (Fluvoxamine,
Suspended
- Severe Acute Respiratory Syndrome Coronavirus 2
- +2 more
- Fluvoxamine
- Placebo
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 14, 2021
Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-CoV2
- Janus Kinase Inhibitor (ruxolitinib)
- Placebo
-
Sao Paulo, BrazilHospital das Clínicas
Apr 5, 2021
Severe Acute Respiratory Syndrome Coronavirus 2, Metabolic Syndrome, Type 2 Diabetes Trial in Mexico City (metformin glycinate,
Withdrawn
- Severe Acute Respiratory Syndrome Coronavirus 2
- +2 more
- metformin glycinate
- Placebo oral tablet
-
Mexico City, MexicoHospital Juárez de México, OPD
Apr 5, 2021